Watchlist

Watchlist
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack receives $5M milestone payment from Shire
Merrimack Pharmaceuticals (NASDAQ: MACK ) has received a $5M milestone payment from Shire, triggered by the sale of ONIVYDE in the first major non-European, non-Asian country, pursuant to the terms of Merrimack's asset sale to Ipsen in 2017. More news on: Merrimack Pharmaceuticals, Healt…
Merrimack Receives $5 Million Milestone Payment from Shire
CAMBRIDGE, Mass. , Sept.20, 2018 /PRNewswire/ --Merrimack Pharmaceuticals, Inc.(Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced that it has received a $5 million milestone payment from Shire, triggered by the sale of…
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack Pharmaceuticals, Inc. (MACK)